Parkman Healthcare Partners LLC Karyopharm Therapeutics Inc. Transaction History

Parkman Healthcare Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $1.71 Million - $2.38 Million	-120,802 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$16.6 - $25.25 $1.58 Million - $2.4 Million	-95,000 Reduced 44.02%	120,802 $2.29 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $4.09 Million - $7.88 Million	-284,198 Reduced 56.84%	215,802 $4.15 Million
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $4.62 Million - $9.84 Million	500,000 New	500,000 $9.59 Million

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.